Dextrose Monohydrate 50% Injection Shortage: Current Availability and Manufacturer Updates

What’s in Shortage

Dextrose Monohydrate 50% Injection (Brand Name: DEXTROSE) is currently listed in a shortage status. This medication is an injection used within the therapeutic categories of Endocrinology/Metabolism, Gastroenterology, and Pediatrics. The shortage was first posted on January 13, 2022, and was last updated on February 12, 2026.

Which Manufacturers Are Affected

The following availability information has been reported for Hospira, Inc., a Pfizer Company:

• Hospira, Inc., a Pfizer Company

  • Presentation: Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-4902-34)
  • Status: Unavailable
  • Notes: Discontinuation of the manufacture of the drug.
  • Contact: 844-646-4398

• Hospira, Inc., a Pfizer Company

  • Presentation: Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02)
  • Status: Available
  • Contact: 844-646-4398

Why There’s a Shortage

The reason provided for the current shortage status is the discontinuation of the manufacture of the drug for specific product presentations.

What Patients Should Do

If you or a family member are prescribed Dextrose Monohydrate 50% Injection, please consider the following steps:

• Consult Your Healthcare Provider: Always speak with your doctor or healthcare professional regarding your treatment plan and any potential impacts this shortage may have on your care. Do not make changes to your medication without professional guidance.
• Speak with Your Pharmacist: Pharmacists can provide the most current information regarding local stock and supply levels.
• Contact the Manufacturer: For specific questions regarding product availability, you may contact Hospira (Pfizer) at 844-646-4398.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider for medical guidance and treatment alternatives.

Source

Information sourced from the FDA Drug Shortage Database.